PortfoliosLab logo

Concert Pharmaceuticals, Inc. (CNCE)

Equity · Currency in USD · Last updated May 21, 2022

Company Info

Trading Data

  • Previous Close$4.49
  • Year Range$2.69 - $4.79
  • EMA (50)$3.47
  • EMA (200)$3.45
  • Average Volume$107.70K
  • Market Capitalization$163.48M

CNCEShare Price Chart


Chart placeholderClick Calculate to get results

CNCEPerformance

The chart shows the growth of $10,000 invested in Concert Pharmaceuticals, Inc. on Feb 14, 2014 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,166 for a total return of roughly -68.34%. All prices are adjusted for splits and dividends.


CNCE (Concert Pharmaceuticals, Inc.)
Benchmark (^GSPC)

CNCEReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M38.58%-12.57%
YTD42.54%-18.14%
6M13.96%-17.07%
1Y16.32%-5.21%
5Y-20.87%10.37%
10Y-12.99%9.60%

CNCEMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

CNCESharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Concert Pharmaceuticals, Inc. Sharpe ratio is 0.11. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


CNCE (Concert Pharmaceuticals, Inc.)
Benchmark (^GSPC)

CNCEDividend History


Concert Pharmaceuticals, Inc. doesn't pay dividends

CNCEDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


CNCE (Concert Pharmaceuticals, Inc.)
Benchmark (^GSPC)

CNCEWorst Drawdowns

The table below shows the maximum drawdowns of the Concert Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Concert Pharmaceuticals, Inc. is 90.74%, recorded on Oct 22, 2021. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.74%Dec 20, 2017967Oct 22, 2021
-69.61%Nov 3, 2015254Nov 3, 2016275Dec 7, 2017529
-52.06%Mar 12, 201450May 21, 2014193Feb 26, 2015243
-22.44%Sep 24, 20153Sep 28, 201512Oct 14, 201515
-21.23%Mar 17, 20159Mar 27, 201546Jun 3, 201555
-19.05%Jun 4, 201518Jun 29, 201550Sep 9, 201568
-11.44%Feb 27, 20156Mar 6, 20154Mar 12, 201510
-9.12%Oct 20, 20155Oct 26, 20155Nov 2, 201510
-8.89%Sep 21, 20152Sep 22, 20151Sep 23, 20153
-4.4%Sep 16, 20151Sep 16, 20152Sep 18, 20153

CNCEVolatility Chart

Current Concert Pharmaceuticals, Inc. volatility is 129.91%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


CNCE (Concert Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Portfolios with Concert Pharmaceuticals, Inc.


Loading data...

More Tools for Concert Pharmaceuticals, Inc.